Judith Krikke-Workel

A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHD

J. Buitelaar, J. Gádoros, V. Harpin, 2004, European Child & Adolescent Psychiatry.

A Short-Term, Multicenter, Placebo-Controlled, Randomized Withdrawal Study of a Metabotropic Glutamate 2/3 Receptor Agonist Using an Electronic Patient-Reported Outcome Device in Patients With Schizophrenia

B. Kinon, Simin K. Baygani, V. Stauffer, 2014, Journal of clinical psychopharmacology.

A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical Studies

G. Dawson, R. Mohs, C. Harmer, 2016, Neuropsychopharmacology.

A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical Studies

G. Dawson, R. Mohs, C. Harmer, 2016, Neuropsychopharmacology.

Lasmiditan efficacy in the acute treatment of migraine was independent of prior response to triptans: Findings from the CENTURION study

J. Krege, U. Reuter, S. Dowsett, 2021, Cephalalgia : an international journal of headache.

Randomized, controlled trial of lasmiditan over four migraine attacks: Findings from the CENTURION study

M. Ashina, J. Krege, U. Reuter, 2021, Cephalalgia : an international journal of headache.